The global Oral Medications for Erectile Dysfunction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Oral medications for erectile dysfunction (ED) are a group of prescription drugs designed to help men achieve and maintain an erection sufficient for sexual activity. The most commonly used oral medications for ED are phosphodiesterase type 5 (PDE5) inhibitors, which include sildenafil, tadalafil, vardenafil, and avanafil.
North American market for Oral Medications for Erectile Dysfunction is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Medications for Erectile Dysfunction is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Medications for Erectile Dysfunction include Pfizer, Eli Lilly, Metuchen Pharmaceuticals, SK Chemicals Life Science, Dong-A Pharmaceutical, °ä°ù¾±²õ³Ùá±ô¾±²¹, Hetero, Teva, Aurobindo Pharma, Watson Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Medications for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Medications for Erectile Dysfunction.
The Oral Medications for Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral Medications for Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Medications for Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Eli Lilly
Metuchen Pharmaceuticals
SK Chemicals Life Science
Dong-A Pharmaceutical
°ä°ù¾±²õ³Ùá±ô¾±²¹
Hetero
Teva
Aurobindo Pharma
Watson Laboratories
Cipla
Sun Pharma
Lupin
MSN
Zydus
Alkem
Amneal Pharmaceuticals
Dr. Reddy's Laboratories
Chartwell
Eugia Pharma
Qilu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yangtze River Pharmaceutical
Sichuan Kelun Pharmaceutical
Regenex Pharmaceutical
Haisco Pharmaceutical
Shanghai Huilun Pharmaceutical
Segment by Type
Sildenafil
Tadalafil
Vardenafil
Avanafil
Mirodenafil
Udenafil
Lodenafil
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Medications for Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Medications for Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Oral Medications for Erectile Dysfunction Market Overview
1.1 Product Definition
1.2 Oral Medications for Erectile Dysfunction by Type
1.2.1 Global Oral Medications for Erectile Dysfunction Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Vardenafil
1.2.5 Avanafil
1.2.6 Mirodenafil
1.2.7 Udenafil
1.2.8 Lodenafil
1.2.9 Others
1.3 Oral Medications for Erectile Dysfunction by Application
1.3.1 Global Oral Medications for Erectile Dysfunction Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oral Medications for Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Oral Medications for Erectile Dysfunction Revenue 2019-2030
1.4.2 Global Oral Medications for Erectile Dysfunction Sales 2019-2030
1.4.3 Global Oral Medications for Erectile Dysfunction Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Medications for Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Oral Medications for Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Medications for Erectile Dysfunction Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oral Medications for Erectile Dysfunction, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Product Type & Application
2.7 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Date of Enter into This Industry
2.8 Global Oral Medications for Erectile Dysfunction Market Competitive Situation and Trends
2.8.1 Global Oral Medications for Erectile Dysfunction Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Medications for Erectile Dysfunction Players Market Share by Revenue
2.8.3 Global Oral Medications for Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Medications for Erectile Dysfunction Market Scenario by Region
3.1 Global Oral Medications for Erectile Dysfunction Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Medications for Erectile Dysfunction Sales by Region: 2019-2030
3.2.1 Global Oral Medications for Erectile Dysfunction Sales by Region: 2019-2024
3.2.2 Global Oral Medications for Erectile Dysfunction Sales by Region: 2025-2030
3.3 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2019-2030
3.3.1 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2019-2024
3.3.2 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2025-2030
3.4 North America Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.4.3 North America Oral Medications for Erectile Dysfunction Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.5.3 Europe Oral Medications for Erectile Dysfunction Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Medications for Erectile Dysfunction Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Medications for Erectile Dysfunction Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Medications for Erectile Dysfunction Sales by Region (2019-2030)
3.6.3 Asia Pacific Oral Medications for Erectile Dysfunction Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.7.3 Latin America Oral Medications for Erectile Dysfunction Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Medications for Erectile Dysfunction Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Medications for Erectile Dysfunction Sales by Type (2019-2030)
4.1.1 Global Oral Medications for Erectile Dysfunction Sales by Type (2019-2024)
4.1.2 Global Oral Medications for Erectile Dysfunction Sales by Type (2025-2030)
4.1.3 Global Oral Medications for Erectile Dysfunction Sales Market Share by Type (2019-2030)
4.2 Global Oral Medications for Erectile Dysfunction Revenue by Type (2019-2030)
4.2.1 Global Oral Medications for Erectile Dysfunction Revenue by Type (2019-2024)
4.2.2 Global Oral Medications for Erectile Dysfunction Revenue by Type (2025-2030)
4.2.3 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Type (2019-2030)
4.3 Global Oral Medications for Erectile Dysfunction Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Medications for Erectile Dysfunction Sales by Application (2019-2030)
5.1.1 Global Oral Medications for Erectile Dysfunction Sales by Application (2019-2024)
5.1.2 Global Oral Medications for Erectile Dysfunction Sales by Application (2025-2030)
5.1.3 Global Oral Medications for Erectile Dysfunction Sales Market Share by Application (2019-2030)
5.2 Global Oral Medications for Erectile Dysfunction Revenue by Application (2019-2030)
5.2.1 Global Oral Medications for Erectile Dysfunction Revenue by Application (2019-2024)
5.2.2 Global Oral Medications for Erectile Dysfunction Revenue by Application (2025-2030)
5.2.3 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Application (2019-2030)
5.3 Global Oral Medications for Erectile Dysfunction Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Oral Medications for Erectile Dysfunction Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Oral Medications for Erectile Dysfunction Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Metuchen Pharmaceuticals
6.3.1 Metuchen Pharmaceuticals Company Information
6.3.2 Metuchen Pharmaceuticals Description and Business Overview
6.3.3 Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Product Portfolio
6.3.5 Metuchen Pharmaceuticals Recent Developments/Updates
6.4 SK Chemicals Life Science
6.4.1 SK Chemicals Life Science Company Information
6.4.2 SK Chemicals Life Science Description and Business Overview
6.4.3 SK Chemicals Life Science Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SK Chemicals Life Science Oral Medications for Erectile Dysfunction Product Portfolio
6.4.5 SK Chemicals Life Science Recent Developments/Updates
6.5 Dong-A Pharmaceutical
6.5.1 Dong-A Pharmaceutical Company Information
6.5.2 Dong-A Pharmaceutical Description and Business Overview
6.5.3 Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.5.5 Dong-A Pharmaceutical Recent Developments/Updates
6.6 °ä°ù¾±²õ³Ùá±ô¾±²¹
6.6.1 °ä°ù¾±²õ³Ùá±ô¾±²¹ Company Information
6.6.2 °ä°ù¾±²õ³Ùá±ô¾±²¹ Description and Business Overview
6.6.3 °ä°ù¾±²õ³Ùá±ô¾±²¹ Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.6.4 °ä°ù¾±²õ³Ùá±ô¾±²¹ Oral Medications for Erectile Dysfunction Product Portfolio
6.6.5 °ä°ù¾±²õ³Ùá±ô¾±²¹ Recent Developments/Updates
6.7 Hetero
6.7.1 Hetero Company Information
6.7.2 Hetero Description and Business Overview
6.7.3 Hetero Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hetero Oral Medications for Erectile Dysfunction Product Portfolio
6.7.5 Hetero Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Oral Medications for Erectile Dysfunction Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Watson Laboratories
6.10.1 Watson Laboratories Company Information
6.10.2 Watson Laboratories Description and Business Overview
6.10.3 Watson Laboratories Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Watson Laboratories Oral Medications for Erectile Dysfunction Product Portfolio
6.10.5 Watson Laboratories Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Company Information
6.11.2 Cipla Description and Business Overview
6.11.3 Cipla Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Oral Medications for Erectile Dysfunction Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Sun Pharma
6.12.1 Sun Pharma Company Information
6.12.2 Sun Pharma Description and Business Overview
6.12.3 Sun Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.12.5 Sun Pharma Recent Developments/Updates
6.13 Lupin
6.13.1 Lupin Company Information
6.13.2 Lupin Description and Business Overview
6.13.3 Lupin Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Oral Medications for Erectile Dysfunction Product Portfolio
6.13.5 Lupin Recent Developments/Updates
6.14 MSN
6.14.1 MSN Company Information
6.14.2 MSN Description and Business Overview
6.14.3 MSN Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MSN Oral Medications for Erectile Dysfunction Product Portfolio
6.14.5 MSN Recent Developments/Updates
6.15 Zydus
6.15.1 Zydus Company Information
6.15.2 Zydus Description and Business Overview
6.15.3 Zydus Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zydus Oral Medications for Erectile Dysfunction Product Portfolio
6.15.5 Zydus Recent Developments/Updates
6.16 Alkem
6.16.1 Alkem Company Information
6.16.2 Alkem Description and Business Overview
6.16.3 Alkem Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Alkem Oral Medications for Erectile Dysfunction Product Portfolio
6.16.5 Alkem Recent Developments/Updates
6.17 Amneal Pharmaceuticals
6.17.1 Amneal Pharmaceuticals Company Information
6.17.2 Amneal Pharmaceuticals Description and Business Overview
6.17.3 Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Product Portfolio
6.17.5 Amneal Pharmaceuticals Recent Developments/Updates
6.18 Dr. Reddy's Laboratories
6.18.1 Dr. Reddy's Laboratories Company Information
6.18.2 Dr. Reddy's Laboratories Description and Business Overview
6.18.3 Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Product Portfolio
6.18.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.19 Chartwell
6.19.1 Chartwell Company Information
6.19.2 Chartwell Description and Business Overview
6.19.3 Chartwell Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Chartwell Oral Medications for Erectile Dysfunction Product Portfolio
6.19.5 Chartwell Recent Developments/Updates
6.20 Eugia Pharma
6.20.1 Eugia Pharma Company Information
6.20.2 Eugia Pharma Description and Business Overview
6.20.3 Eugia Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Eugia Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.20.5 Eugia Pharma Recent Developments/Updates
6.21 Qilu Pharmaceutical
6.21.1 Qilu Pharmaceutical Company Information
6.21.2 Qilu Pharmaceutical Description and Business Overview
6.21.3 Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.21.5 Qilu Pharmaceutical Recent Developments/Updates
6.22 Guangzhou Baiyunshan Pharmaceutical
6.22.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.22.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.22.3 Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.22.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
6.23 Yangtze River Pharmaceutical
6.23.1 Yangtze River Pharmaceutical Company Information
6.23.2 Yangtze River Pharmaceutical Description and Business Overview
6.23.3 Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.23.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.24 Sichuan Kelun Pharmaceutical
6.24.1 Sichuan Kelun Pharmaceutical Company Information
6.24.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.24.3 Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.24.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.25 Regenex Pharmaceutical
6.25.1 Regenex Pharmaceutical Company Information
6.25.2 Regenex Pharmaceutical Description and Business Overview
6.25.3 Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.25.5 Regenex Pharmaceutical Recent Developments/Updates
6.26 Haisco Pharmaceutical
6.26.1 Haisco Pharmaceutical Company Information
6.26.2 Haisco Pharmaceutical Description and Business Overview
6.26.3 Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.26.5 Haisco Pharmaceutical Recent Developments/Updates
6.27 Shanghai Huilun Pharmaceutical
6.27.1 Shanghai Huilun Pharmaceutical Company Information
6.27.2 Shanghai Huilun Pharmaceutical Description and Business Overview
6.27.3 Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.27.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Medications for Erectile Dysfunction Industry Chain Analysis
7.2 Oral Medications for Erectile Dysfunction Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Medications for Erectile Dysfunction Production Mode & Process
7.4 Oral Medications for Erectile Dysfunction Sales and Marketing
7.4.1 Oral Medications for Erectile Dysfunction Sales Channels
7.4.2 Oral Medications for Erectile Dysfunction Distributors
7.5 Oral Medications for Erectile Dysfunction Customers
8 Oral Medications for Erectile Dysfunction Market Dynamics
8.1 Oral Medications for Erectile Dysfunction Industry Trends
8.2 Oral Medications for Erectile Dysfunction Market Drivers
8.3 Oral Medications for Erectile Dysfunction Market Challenges
8.4 Oral Medications for Erectile Dysfunction Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Pfizer
Eli Lilly
Metuchen Pharmaceuticals
SK Chemicals Life Science
Dong-A Pharmaceutical
°ä°ù¾±²õ³Ùá±ô¾±²¹
Hetero
Teva
Aurobindo Pharma
Watson Laboratories
Cipla
Sun Pharma
Lupin
MSN
Zydus
Alkem
Amneal Pharmaceuticals
Dr. Reddy's Laboratories
Chartwell
Eugia Pharma
Qilu Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yangtze River Pharmaceutical
Sichuan Kelun Pharmaceutical
Regenex Pharmaceutical
Haisco Pharmaceutical
Shanghai Huilun Pharmaceutical
Ìý
Ìý
*If Applicable.